Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China (2017YFC1200503)

This publication has 37 references indexed in Scilit: